Emerging in the landscape of obesity management, retatrutide is a unique strategy. Unlike many current medications, retatrutide works as a double agonist, simultaneously targeting both GLP-like peptide-1 (GLP-1) and https://janaqxld272323.myparisblog.com/39255808/a-new-retatrutide-this-glp-gip-binding-site-agonist